As I stated many times before the key problem with this company is volume.
It states it is building its US exposure with a BDM but it useless having that resource when you can produce volume for such a market.
This is why Bondi Partners cannot get a deal.
Elume are producing 30m/month and rising.
HIV test yes have huge potential in 3rd World counties but they want only a cheap product.
Atomo cannot make volume hence they get bits and pieces small orders that dont add up to much.
John talks a big book but cannot deliver.
The partners so far have been crap.
Very disappointing management
AT1 chart, page-364
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $15.98M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.5¢ | $440 | 16.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 168821 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 118836 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 168821 | 0.025 |
4 | 857050 | 0.024 |
4 | 1100391 | 0.023 |
6 | 467973 | 0.022 |
3 | 194292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 118836 | 2 |
0.027 | 26459 | 2 |
0.028 | 196971 | 3 |
0.029 | 425248 | 5 |
0.030 | 434288 | 7 |
Last trade - 10.47am 23/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online